NDEs positive for L1CAM were also used as a tool to assess the concentration of proteins of interest in the serum of PD patients who participated in a clinical trial for the study of possible beneficial effects of a diabetes type 2 treatment drug (Athauda et al., 2019). The gene discussed is L1CAM; the disease is Parkinson disease.